Spravato or TMS First: How Panic, Dissociation, and Schedule Change the Decision

Treatment-Resistant Depression · Hayward, CA

SPRAVATO and TMS are both used for treatment-resistant depression, but they ask very different things from the patient. The choice often comes down to what a person can actually tolerate — and that is a more useful question than which treatment is “stronger.”

TMS usually means showing up almost every weekday for several weeks. The Clinical TMS Society consensus notes that many large TMS studies used treatment five days a week for four to six weeks, sometimes up to 36 sessions.^[1] TMS is non-medication and does not cause dissociation, but the treatment can feel physically uncomfortable, often described as a tapping or snapping against the scalp.^[2]

SPRAVATO is esketamine nasal spray, FDA-approved for adults with treatment-resistant depression. It does not require near-daily visits in the same way, but each session is more medically involved. Patients are monitored after dosing, need a ride home, and should not drive or do anything requiring full alertness until the next day after restful sleep. Common adverse reactions include dissociation, dizziness, nausea, sedation, vertigo, anxiety, increased blood pressure, vomiting, feeling drunk, and headache.^[3]

So the question is not “which one is easier?” The question is: which burden is safer and more realistic for this patient?

When SPRAVATO may fit before TMS

SPRAVATO may come first when the TMS schedule is not realistic, when depression has not responded to standard antidepressants, or when the patient and provider want a monitored treatment that works through a different biological pathway.

Esketamine is not just another SSRI. It is connected to glutamate signaling, which is involved in synaptic plasticity and the brain’s ability to form new patterns.^[3] That is why our team usually recommends pairing SPRAVATO with therapy, behavioral activation, sleep rhythm, and structured self-work. The treatment may create a window for change, but the patient still needs to use that window well.

SPRAVATO may be a poor fit, or at least need extra preparation, for patients who are highly sensitive to dissociation, derealization, panic sensations, feeling out of control, or sudden internal shifts. The FDA label specifically lists dissociation, sedation, anxiety, and blood pressure increases among the important risks, so this should be screened for directly rather than minimized.^[3]

When TMS may fit better

TMS may fit better when the patient wants to avoid a psychoactive session experience. There is no intoxicated feeling, no dissociation, and no requirement for a ride home after each session. For patients with panic disorder, derealization, or a fear of altered states, that can matter a lot.

The tradeoff is commitment and physical tolerance. TMS requires frequent attendance, and some patients experience scalp discomfort, headache, dizziness, fatigue, or temporary anxiety or irritability — though anxiety and irritability are among the less common effects in the consensus literature.^[2] So TMS may be easier psychologically for someone who fears dissociation, but harder practically for someone who cannot manage near-daily appointments.

The takeaway

Some patients choose SPRAVATO before TMS because the schedule, biology, and treatment burden fit them better. Others choose TMS first because avoiding dissociation, sedation, and altered sensations matters more.

Neither treatment is automatically better. SPRAVATO asks whether the patient can tolerate monitored esketamine effects and use the neuroplastic window intentionally. TMS asks whether the patient can tolerate scalp stimulation and commit to a frequent treatment schedule. The best choice is the one that fits the depression, the nervous system, and the patient’s real life.

By Nefretiri Abat, JD, PMHNP-BC — Founder, Exxceed Wellness, Hayward CA. This article is for educational purposes only and is not medical advice. SPRAVATO, TMS, depression severity, panic symptoms, dissociation, blood pressure changes, substance use, suicidal thoughts, and treatment-resistant depression require individualized evaluation by a licensed clinician. If you are having thoughts of harming yourself, call or text 988 (the Suicide & Crisis Lifeline) or go to your nearest emergency department.